• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌经肛门切除术

Transanal excision of rectal carcinoma.

作者信息

Frazee R C, Patel R, Belew M, Roberts J W, Hendricks J C

机构信息

Scott & White Clinic, Temple, Texas, USA.

出版信息

Am Surg. 1995 Aug;61(8):714-7.

PMID:7618812
Abstract

Twenty-two men and 16 women with a mean age of 67 years were treated for rectal carcinoma by transanal excision. Patients presented with rectal bleeding (63%), change in bowel habits (11%), rectal pain (4%), or were asymptomatic and discovered on screening proctosigmoidoscopy (22%). The tumors were located from the anal verge to 8 cm proximally and ranged in size from 1 to 4 cm. Pathologic findings included adenocarcinoma (92%), squamous cell carcinoma (4%), and cloacogenic carcinoma (4%). Postoperative hospitalization averaged two days (0 to 29 days). One patient died of a perioperative myocardial infarction for an operative mortality of 3 per cent. Morbidity was 7 per cent and included urinary retention and pneumonia. Postoperative radiation therapy was administered to 11 patients with either undifferentiated tumors or invasion into the muscularis propria. Follow-up in these 38 patients averaged 30 months. One patient died of metastatic carcinoma, and two patients developed local recurrence that was treated successfully by a low anterior resection or abdominoperineal resection. Transanal excision of rectal carcinoma can be performed in properly selected patients with good overall survival and local control.

摘要

22名男性和16名女性平均年龄67岁,接受了经肛门切除术治疗直肠癌。患者表现为直肠出血(63%)、排便习惯改变(11%)、直肠疼痛(4%),或无症状,在筛查乙状结肠镜检查时发现(22%)。肿瘤位于距肛缘至近端8厘米处,大小从1至4厘米不等。病理结果包括腺癌(92%)、鳞状细胞癌(4%)和泄殖腔源癌(4%)。术后住院时间平均为两天(0至29天)。1例患者死于围手术期心肌梗死,手术死亡率为3%。发病率为7%,包括尿潴留和肺炎。11例肿瘤未分化或侵犯固有肌层的患者接受了术后放疗。这38例患者的随访时间平均为30个月。1例患者死于转移性癌,2例患者出现局部复发,通过低位前切除术或腹会阴联合切除术成功治疗。经肛门切除直肠癌可在适当选择的患者中进行,总体生存率和局部控制良好。

相似文献

1
Transanal excision of rectal carcinoma.直肠癌经肛门切除术
Am Surg. 1995 Aug;61(8):714-7.
2
Results of long-term follow-up for transanal excision for rectal cancer.直肠癌经肛门切除术的长期随访结果。
Am Surg. 2003 Aug;69(8):675-8; discussion 678.
3
Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.多媒体文章。腹腔镜超低位前切除术联合结肠J形贮袋肛管吻合术。
Dis Colon Rectum. 2008 Nov;51(11):1710-1. doi: 10.1007/s10350-008-9322-4. Epub 2008 Aug 5.
4
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.部分T3期直肠癌患者术前放化疗后采用局部切除的长期结果。
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105. doi: 10.1016/j.ijrobp.2004.04.062.
5
Transanal local wide excision for rectal adenocarcinoma.经肛门局部广泛切除治疗直肠腺癌。
Hepatogastroenterology. 2005 Mar-Apr;52(62):460-3.
6
Surgical salvage of recurrent rectal cancer after transanal excision.经肛门切除术后复发性直肠癌的手术挽救治疗。
Dis Colon Rectum. 2005 Jun;48(6):1169-75. doi: 10.1007/s10350-004-0930-3.
7
Transanal endoscopic microsurgery for excision of rectal lesions: technique and initial results.经肛门内镜显微手术切除直肠病变:技术与初步结果
Surg Laparosc Endosc Percutan Tech. 2000 Dec;10(6):372-8.
8
Transanal endoscopic microsurgical resection of pT1 rectal tumors.经肛门内镜显微手术切除pT1期直肠肿瘤
Dis Colon Rectum. 2006 Feb;49(2):164-8. doi: 10.1007/s10350-005-0269-4.
9
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
10
Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.低位直肠腺癌经腹会阴联合切除术的发病率和死亡率
Rev Invest Clin. 2001 Sep-Oct;53(5):388-95.

引用本文的文献

1
Tolerability and Safety Assessment of Adjuvant Chemoradiotherapy with S-1 after Limited Surgery for T1 or T2 Lower Rectal Cancer.T1或T2期低位直肠癌有限手术后辅助化疗联合S-1同步放化疗的耐受性和安全性评估
Cancers (Basel). 2024 Sep 30;16(19):3360. doi: 10.3390/cancers16193360.
2
Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer.辅助化疗和放疗联合 S-1 方案在 T1 或 T2 期低位直肠癌有限手术后的耐受性和安全性。
Int J Clin Oncol. 2021 Nov;26(11):2046-2052. doi: 10.1007/s10147-021-01998-6. Epub 2021 Jul 27.
3
Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
高危T1至T2期低位直肠癌局部切除术后的术后放化疗:一项单臂、多机构、II期临床试验的结果
Dis Colon Rectum. 2017 Sep;60(9):914-921. doi: 10.1097/DCR.0000000000000870.